Background
==========

Myocarditis may occasionally mimic acute myocardial infarction, with a similar clinical presentation characterized by chest pain, ECG changes consistent with acute coronary syndromes, and serum markers increment \[[@B1]-[@B3]\]. We have previously reported, in a cohort of 11 young male patients, a clinical condition consistent with myocarditis and characterized by ST segment elevation, serum markers release and good short term outcome \[[@B4]\]. In the present study we describe our updated experience with a larger case series (21 patients) and an extended follow up.

Methods
=======

From January 1^st^, 1998 to December 31th 2009, 21 patients with the following clinical/ECG pattern were admitted to the Coronary Care Unit of a Southern Italian small town (Galatina). All patients were young; all but one was males; the coronary risk profile was low: 11 were light smokers (less than 10 cigarettes/day) and no one suffered from hypertension or diabetes. Hospital admission was needed for prolonged chest pain with ECG changes (ST elevation \> 1 mm in at least two leads) and serum markers increment.

In all patients ECG, cardiac enzymes assay and rest echocardiogram was obtained daily. In 8 patients, RNA-enterovirus search was performed by PCR-method on stool and saliva specimens. Coronary angiography was performed in all patients during the acute phase (in 3 cases at hospital admission). In 5 patients in whom the admission diagnosis was STEMI, thrombolysis with r-TPA was performed; in these, fibrinogen and D-dimer levels were evaluated before and after treatment. The remaining patients received only aspirin, associated with heparin in 9.

After discharge, all patients were followed-up for 65.6 ± 49.1 months (range 1-130), with clinical evaluation, ECG, echocardiogram and exercise stress-test. No medication was indicated at hospital discharge.

The study was approved by our institutional review committee. All patients gave informed consent for inclusion in the study.

Results
=======

Figure [1](#F1){ref-type="fig"} shows a characteristic pattern of presentation in our population. The typical sample case is represented by a young man presenting with typical chest pain, normal global LV function, and ECG modification consistent with acute myocardial ischemia, normal coronary arteries and abnormal levels of serum markers of myocardial damage. The main clinical, laboratory and electrocardiographic findings are listed in table [1](#T1){ref-type="table"}. All patients were young (mean age 27.9 ± 7.02 years, range 17-42), 20 were males, no one was a heavy smoker but 11 were light smokers. All patients but one had a recent history of flu-like episode, with fever and diarrhoea. The only young female showed a hairy chest.

![**A typical sample case (case 21). See text**.](1476-7120-9-1-1){#F1}

###### 

Clinical, laboratory and electrocardiographic findings

  Patient, sex, age (years)   Admission month   Recent Fever   CK-MB, U/L admission/peak (Troponine I, ng/ml)   Coronary risk factors (smoke)   ECG leads with ST elevation on admission ECG   Abnormal T waves on discharge ECG   Follow up (months)   Relapse
  --------------------------- ----------------- -------------- ------------------------------------------------ ------------------------------- ---------------------------------------------- ----------------------------------- -------------------- ---------
   **16) 1 SW, M, 19**        **March**         **+**          **71/73 (NA)**                                   **0**                           **I, aVL, V4-V6**                              **Diphasic V4-V6**                  **130**              **no**
                                                                                                                                                                                                                                                        
  **2 TG, M, 24**             **November**      **+**          **39/83 (NA)**                                   **0**                           **I, aVL, V6**                                 **Negative I, II, aVL, V5,V6**      **122**              **yes**
                                                                                                                                                                                                                                                        
  **3 CE, M, 32**             **December**      \-             **76/77 (NA)**                                   **0**                           **I, II, V4-V6**                               **Negative V4-V6**                  **121**              **no**
                                                                                                                                                                                                                                                        
  **4 AA, M, 38**             **February**      **+**          **67/120 (NA)**                                  **1 (smoke)**                   **II, III, aVF, V5, V6**                       **Diphasic III, aVF**               **119**              **no**
                                                                                                                                                                                                                                                        
  **5 CM, M, 30**             **April**         **+**          **91/130 (NA)**                                  **1 (smoke)**                   **II, III, aVF**                               **Negative III,V6**                 **105**              **no**
                                                                                                                                                                                                                                                        
  **6 BM, M, 17**             **January**       **+**          **60/60 (NA)**                                   **0**                           **I, II, aVF, V4-V6**                          **Negative II, III, aVF, V4-V6**    **96**               **no**
                                                                                                                                                                                                                                                        
   **7 CR, M, 32**            **August**        **+**          **24/43 (17)**                                   **1 (smoke)**                   **II, III, aVF,V4-V6**                         **None**                            **77**               **no**
                                                                                                                                                                                                                                                        
  **8 CG, M, 39**             **October**       **+**          **17/30 (16)**                                   **1 (smoke)**                   **I, aVL**                                     **Negative I, aVL, V6**             **63**               **no**
                                                                                                                                                                                                                                                        
  **9 SS, M, 28**             **December**      **+**          **23/23 (10.5)**                                 **1 (smoke)**                   **II, III, aVF, V5-V6**                        **None**                            **61**               **no**
                                                                                                                                                                                                                                                        
  **10 CR, M, 21**            **April**         **+**          **34/34 (5.4)**                                  **1 (smoke)**                   **II, III, aVF, V6**                           **None**                            **57**               **no**
                                                                                                                                                                                                                                                        
  **11 CR, M, 28**            **April**         **+**          **17/17 (3.6)**                                  **0**                           **I, aVL**                                     **Flat I, aVL**                     **57**               **no**
                                                                                                                                                                                                                                                        
  **12 SM, M, 26**            **July**          **+**          **8/14 (4.3)**                                   **0**                           **II, III, aVF**                               **Negative II, III, aVF**           **54**               **yes**
                                                                                                                                                                                                                                                        
  **13 CA, M, 19**            **April**         **+**          **21/21 (16.1)**                                 **0**                           **II, V6**                                     **None**                            **45**               **no**
                                                                                                                                                                                                                                                        
  **14 LF, M, 42**            **October**       **+**          **10/12 (5.3)**                                  **0**                           **I, II, III, aVF, V6**                        **Negative III, V6**                **38**               **no**
                                                                                                                                                                                                                                                        
  **15 AG, M, 20**            **April**         **+**          **55/55 (29)**                                   **1 (smoke)**                   **I, aVL, V2-V6**                              **Negative V4-V6**                  **38**               **no**
                                                                                                                                                                                                                                                        
  **16 DA, M, 33**            **March**         **+**          **7/16 (2)**                                     **1 (smoke)**                   **II, III, aVF, V5-V6**                        **Flat II**                         **34**               **no**
                                                                                                                                                                                                                                                        
  **17 DM, F, 31**            **April**         **+**          **19/19 (9.4)**                                  **1 (smoke)**                   **II, III, aVF**                               **Negative III**                    **33**               **no**
                                                                                                                                                                                                                                                        
  **18 IA, M, 25**            **February**      **+**          **30/30 (3.4)**                                  **0**                           **II, III, aVF**                               **Negative II, III, aVF**           **23**               **no**
                                                                                                                                                                                                                                                        
  **19 FR, M, 35**            **December**      **+**          **14/14 (1.9)**                                  **1 (smoke)**                   **II, III,, aVF**                              **None**                            **13**               **no**
                                                                                                                                                                                                                                                        
  **20 AM, M, 27**            **January**       **+**          **19/24 (2,3)**                                  **0**                           **II, III, aVF**                               **Negative II,III, aVF**            **1**                **no**
                                                                                                                                                                                                                                                        
  **21 PF, M. 18**            **January**       **+**          **23/28 (3,56)**                                 **1 (smoke)**                   **I, aVL, V2-V6**                              **Negative I, II, aVL, V2-V6**      **1**                **no**

NA = not available

\+ = present

\- = absent

All patients were admitted for acute chest pain that had started 50-425 minutes before admission. The characteristics of chest pain were always typical for acute coronary syndrome: midsternal constrictive pain, often radiating to the left arm and/or to the neck. Physical examination was unremarkable; in particular, no pericardial friction rub was heard and no signs of heart failure were evident. The admission ECG showed upward concave ST segment elevation in all cases (inferior in 5, lateral in 5, infero-lateral in 10, anterior in 1), followed, in the subsequent days, by T wave inversion; no abnormal Q waves, however, appeared in any patient. Figure [2](#F2){ref-type="fig"} reports a typical example of ECG evolution (case 4).

![**Electrocardiograms recorded on admission (A) and discharge (B) from patient n. 4**.](1476-7120-9-1-2){#F2}

Cardiac serum enzymes, as well as troponin, were abnormal, but with an atypical pattern, being increased on admission (even when the elapsed time from chest pain onset was very short), with a relatively low peak, and late normalization (5-8 days). At echocardiography, no wall motion abnormality was detected in 17 patients, whereas a transient regional dysfunction, lasting only a few days, was observed in 4 cases, with good correspondence between the echocardiographic location of wall motion impairment and the ECG leads showing ST segment and/or T wave abnormality. Ejection fraction (Simpson\'s rule) was normal in all patients (mean 67 ± 11%).

In 5 patients (n. 2, 4, 5, 10, 11), an initial diagnosis of STEMI prompted thrombolytic treatment with r-tPA. In 4 of these, fall of serum fibrinogen levels, not associated to any D-dimer increase, was observed. Coronary angiography showed normal coronary arteries in all cases, including the subset (n = 3) who underwent the exam immediately after hospital admission. Screening for enterovirus, performed in 8 patients, was positive in 5.

The clinical course was uneventful in 19 cases. A transient third sound was heard in one patient, without any other sign or symptom of heart failure. In one case, frequent asymptomatic ventricular arrhythmias (polymorphic ventricular ectopic beats and runs of non sustained ventricular tachycardia) occurred during the first 2 days. All patients were discharged in good clinical state, 8.5 ± 2.8 days after admission.

At follow-up, 19/21 cases remained asymptomatic, with normal physical findings, ECG, echocardiogram, and exercise stress-test. In two cases (2 and 12), a relapse was observed, 89 and 45 months after the first episode. In both patients, the recurrence of the clinical condition was preceded by a flu-like disease, with fever and diarrhoea, with same clinical presentation and ECG and serum modifications as in the first episode. Coronary angiography was repeated in one of these patients and did not show significant abnormalities.

Discussion
==========

Our patients suffered from an acute non-coronary cardiac disease characterized by chest pain, ST segment elevation, enzyme and troponin release, normal coronary angiogram, good prognosis and relative risk of late relapse (10%). This acute condition affected mostly young males. Several feature are likely to exclude an ischemic origin: a) young age and low coronary risk profile; b) atypical ECG evolution, with slow ST segment normalization and no Q wave appearance; c) atypical pattern of bio-markers release, with high admission value even when hospital admission occurred within 1 hour from pain onset, myocardial involving before symptoms appereance; d) absence of D-dimer level elevation in spite of marked fibrinogen decrease following treatment with r-TPA, an observation suggesting the likelihood that no intravascular thrombi were present; e) normal coronary angiogram.

It is likely that the clinical condition may be of viral origin: a) all but one patients experienced fever with flu-like symptoms, often associated with diarrhoea, a few days before admission; b) the disease shows a seasonal prevalence (maximal incidence in winter and spring, with peak in April), parallel to that of flu-like viral infections in our region; c) the evidence of enterovirus infection in 5 out the 8 cases in which PCR research was performed.

An intriguing finding is that all but one of our patients was of male gender. According to the small sample size, this could be a casual phenomenon. Alternatively, it could represent the clinical counterpart of an experimental observation pointing out that some viral strains induce myocarditis only in adult male animals \[[@B5]\]. Coxackievirus B3 infection results in cardiac inflammation in male, but not in female B1.Tg.Ealpha mice \[[@B6]\]. In addition, although weanling male BALB/c mice show minimal cardiac injury after infection, young adult male animals develop severe myocarditis while female age-matched mice do not \[[@B7]\]. Moreover, female animals given testosterone demonstrate in their hearts ten times higher virus levels than female animals given estradiol \[[@B8]\]. Testosterone could affect susceptibility to infection by increasing virus receptor expression on endothelial cells and myocites, and/or by influencing the immune-response \[[@B9],[@B10]\]. It should be pointed out that the only young woman in our population had a hairy chest, a phenomenon that could suggest a possible role of testosterone in favouring a presumptive viral myocarditis. Interestingly enough, the disease can relapse, aven after many years, with the same clinical/electrocardiographic presentation. The characteristics of the clinical relapse pose a viral etiology of the disease, with a likely immune pathogenesis \[[@B11]\]. Finally, a warning should be recommended to physicians before treating patients with atypical clinical presentation for myocardial infarction. There are a few features that physicians should check in order to avoid potential potential life-threatening side effects of thrombolysis: young age; male sex; low coronary risk profile; concomitant flu-like symptoms in the few days before admission; atypical electrocardiographic presentation; atypical serum markers release. In such a clinical scenario, coronary angiography is preferable to thrombolysis.

Study Limitations
=================

The diagnosis of presumptive myocarditis was empiric and deductive, based on a very likely (and in some cases proved) recent viral infection, clinical presentation and evolution, ECG pattern, cardiac bio-markers release, and lack of epicardial coronary artery disease. Myocardial biopsy could have resulted in unquestionable demonstration of myocarditis \[[@B12]\], but was not performed because not strictly appropriate in this clinical context \[[@B13]\].

Conclusions
===========

STEMI-like presumptive myocarditis occurring in young males appears as a distinct acute cardiac non-coronary illness whose origin is not unequivocally proved, although viral aetiology is suggested. The disease shares some characteristics with other conditions that mimic acute coronary syndromes but are associated with angiographically normal coronary arteries. In this group, tako-tsubo disease has recently become very popular, and several \"variants\" have been described, with more or less pronounced differences from the original report \[[@B14]\]. Tako-tsubo syndrome, however, is more common in females over 45 years, is often preceded by a psychological stress, and is associated with wall motion abnormalities mainly affecting the apical region \[[@B15]\]. The herewith discussed disease, in contrast, is characterized by male gender prevalence, young age of patients, preceding flu-like disease, and absence of any stereotyped ventricular wall motion involvement (table [2](#T2){ref-type="table"}). Further studies, involving larger cohorts of patients, are necessary to define whether STEMI-like presumptive myocarditis affecting young males is indeed a syndrome deserving further attention.

###### 

Parallelism between \"Galatina\'s\" and tako tsubo like syndromes

  Syndrome                  Galatina\'s   Tako-tsubo like
  ------------------------- ------------- ---------------------
  STEMI-like presentation   yes           yes
                                          
  Usually benign            yes           yes
                                          
  Occasionally recurrence   yes           yes
                                          
  Gender predominance       male          female
                                          
  Age (years)               \< 40         \> 45
                                          
  Prodomal phase            Flu-like      Psycological stress
                                          
  Favourite target region   inferior      apical
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